Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
accomplished, acquaint, acute, adaptability, aggressive, aim, alongside, ambulatory, AORN, attain, Avantor, back, BBPO, biopharma, Biorisk, broader, BSAT, circumventing, comply, depressed, discerning, DoD, earlier, edge, edition, eleven, enlarge, extent, favorable, FINRA, firmly, ForDoz, GPO, IBD, infection, Issuer, Italy, lengthy, Leveraging, Lonza, lot, maximize, microcap, micron, momentum, naked, nationwide, optimistic, ownership, parallel, partnership, pediatric, perfectly, point, posed, prioritizing, proceed, profitabilty, Program, reinforce, relevance, serve, Shuttle, simultaneously, small, strongly, Surgical, ThermoFisher, Titan, Top, trend, true, UK, undermining, unparalleled, Unregistered, unveiled, Vizient, wage, Zealand
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view